[1] Essential Science Indicators placed her in the top one per cent of the pharmacology and toxicology discipline, as measured by volume of publication citations.
[5] Since beginning her research journey, Lall has earned many patents for leading the discovery of plants with potent medicinal qualities; four have been granted by South Africa, three by the United States, and multiple others by the European Union and countries in East Asia.
[2][5] Thus, Lall's research emphasizes the isolation and purification of chemicals in these medicinal plants, contributing to the larger endeavor of making healthcare more globally accessible, and necessitates close collaboration with leaders of the plant-based products industry.
[10] Her research group places significant emphasis on bioprospecting, drug discovery via validation of ethnopharmocological findings, and the commercialisation of active ingredients for pharmaceuticals and cosmeceuticals.
[1][5][8] In this vein, Lall served for a period as coordinator of the DSI Cosmeceutical Consortium, the aim of which was to commercialise indigenous biological resources for cosmetic development.